Browsing Gastroenterology by Issue Date
Now showing items 21-40 of 135
-
Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease.
(Wiley, 2017-01-20)Few studies have reported the systematic use of exclusive enteral nutrition in the perioperative setting. -
P550 Clinical features of demyelination following anti-TNFα therapy.
(Oxford Journals, 2017-02) -
P413 Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for Crohn's disease
(Oxford Journals, 2017-02-01) -
P648 The impact of infliximab therapeutic drug monitoring on decisions made in a virtual biologics clinic for IBD
(Oxford Journals, 2017-02-01) -
Interaction Between NOD2 and Smoking in the Pathogenesis of Crohn's Disease.
(Elsevier, 2017-07) -
Editorial: which iron preparation for patients with IBD?
(Wiley, 2017-07) -
Non selective beta blockers in cirrhosis.
(Elsevier, 2017-08-05) -
A randomised, double-blind, parallel-group trial to assess mercaptopurine versus placebo to prevent or delay recurrence of Crohn’s disease following surgical resection (TOPPIC)
(NIHR, 2017-09)Crohn’s disease (CD) is a chronic, relapsing, inflammatory bowel disease. Up to 65% of patients with CD require an operation to control the disease within 10 years. Both endoscopic and clinical recurrence is common within ... -
Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease.
(Oxford Academic, 2017-12)Virtual biologics clinics are often used to review patients with inflammatory bowel disease receiving biological therapy, with decisions whether to continue, switch, or stop therapy made based on review of symptoms, disease ... -
The Royal Free Hospital 'hub-and-spoke network model' delivers effective care and increased access to liver transplantation.
(Elsevier, 2018-01)'Hub-and-spoke' networks may be one solution to reduce the geographical inequality in access to liver transplantation (LT) and the growing demands on, and saturation of, LT centres. It is not clear if such networks improve ... -
The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease
(Oxford Academic, 2018-03) -
Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.
(Wiley, 2018-04)Primary care faecal calprotectin testing distinguishes inflammatory bowel disease (IBD) from functional gut disorder in young patients presenting with abdominal symptoms; however, previous evaluations have excluded patients ... -
Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
(PLoS, 2018-05)As part of a broader collaborative network of exome sequencing studies, we developed a jointly called data set of 5,685 Ashkenazi Jewish exomes. We make publicly available a resource of site and allele frequencies, which ... -
Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
(NIHR, 2018-06)Protein biomarkers with associations with the activity and outcomes of diseases are being identified by modern proteomic technologies. They may be simple, accessible, cheap and safe tests that can inform diagnosis, prognosis, ... -
Systematic review of definitions and outcome measures for return of bowel function after gastrointestinal surgery.
(Wiley, 2018-10)Ileus is common after gastrointestinal surgery and has been identified as a research priority. Several issues have limited previous research, including a widely accepted definition and agreed outcome measure. This review ... -
Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?
(Taylor & Francis, 2018-10-24)We aimed to understand the way in which therapeutic drug monitoring (TDM) is used, understood and interpreted for anti-TNF agents in IBD. -
Diagnostic accuracy and usability of home calprotectin testing
(European Crohn's and Colitis Organisation, 2019-01)Faecal calprotectin (FC) is a reliable and non-invasive stool biomarker that is useful in monitoring inflammation in patients with IBD. Testing is routinely performed in a laboratory by enzyme-linked immunosorbent assay ...